[Tyr0]-Somatostatin 28 is a somatostatin-28 analog extended with N-terminal tyrosine to facilitate spectroscopic tracking and conjugation. The longer peptide length preserves multiple receptor interaction motifs. Its properties make it ideal for comparing somatostatin-14 and -28 signaling profiles. Researchers apply it to analyze differential receptor engagement and peptide processing.
CAT No: S07005
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More